BIAFW

bioAffinity Tech

• NASDAQ·05/14 14:27

  BIAF Stock Slips Post Q1 Earnings Despite Strength in CyPath Lung

• TipRanks·05/12 14:14

  bioAffinity CyPath Lung Test Sales Surge Sharply

• Benzinga·05/12 13:24

  BioAffinity Technologies Reports April CyPath Lung Diagnostic Unit Sales Up 300% YoY

• TipRanks·05/12 13:24

  BioAffinity says CyPath Lung test unit sales achieved monthly record in April

• Benzinga·05/12 13:19

  bioAffinity Technologies Reports Record Monthly Unit Sales Of CyPath Lung Diagnostic Tests, 300% Increase In Sales YoY

• PUBT·05/12 13:15

  bioAffinity reports April CyPath Lung unit sales jump nearly 300% year over year

• Press release·05/11 12:11

  Based on the provided financial report articles, I generated the title for the article: "Quarterly Report for the Three Months Ended March 31, 2026 (Form 10-Q)" Please note that the title may not be exact, as the provided text appears to be a financial report in XML format, and the title may not be explicitly stated.

• TipRanks·05/08 17:10

  BioAffinity Technologies reports Q1 EPS (81c) vs. ($4.80) last year

• Seeking Alpha·05/08 12:38

  bioAffinity Technologies GAAP EPS of -$0.81, revenue of $1.35M

• Benzinga·05/08 12:38

  bioAffinity Technologies Q1 EPS $(0.81) Beats $(2.70) Estimate, Sales $1.352M Miss $1.553M Estimate

• Dow Jones·05/08 12:34

  *BioAffinity Technologies 1Q Loss/Shr 81c >BIAF

• Dow Jones·05/08 12:33

  *BioAffinity Technologies 1Q Rev $1.35M >BIAF

• Reuters·05/08 12:32

  BIOAFFINITY TECHNOLOGIES INC - TOTAL CONSOLIDATED REVENUE DECREASES 27% TO $1.4 MLN IN Q1 2026

• PUBT·05/08 12:31

  bioAffinity Q1 FY26 net loss widens to $3.6 million; revenue drops 27% to $1.4 million

• Dow Jones·05/08 12:30

  Press Release: bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath(R) Lung